+213.9%
TSCO vs GSK
+101.2%
+112.7%
-52.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.4% | -1.3% | +2.7% | +1.7% |
| 7D | +6.2% | -3.1% | +9.3% | +7.1% |
| 30D | +18.9% | -0.9% | +19.8% | +19.2% |
| 3M | +13.1% | -4.2% | +17.3% | +14.3% |
| 6M | +24.8% | -1.6% | +26.4% | +24.8% |
| YTD | -20.5% | +2.6% | -23.1% | -21.4% |
| 1Y | -25.4% | +6.2% | -31.6% | -27.0% |
| 3Y | +2.0% | +55.0% | -53.0% | -12.1% |
| 5Y | -6.7% | +42.8% | -49.5% | -18.9% |
| 10Y | +213.9% | +102.1% | +111.8% | +139.2% |
| All | +213.9% | +101.2% | +112.7% | +139.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling